These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 345906)

  • 21. Evaluation of three Mycobacterium leprae monoclonal antibodies in mucus and lymph samples from Ziehl-Neelsen stain negative leprosy patients and their household contacts in an Indian community.
    Cardona-Castro N; Ortega-Rodríguez G; Agudelo-Flórez P
    Mem Inst Oswaldo Cruz; 1998; 93(4):487-90. PubMed ID: 9711338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transmission of leprosy within households.
    Rao PS; Karat AB; Kaliaperumal VG; Karat S
    Int J Lepr Other Mycobact Dis; 1975; 43(1):45-54. PubMed ID: 1171831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exacerbation of dimorphous leprosy apparently due to BCG vaccination.
    Wright FJ
    Lepr Rev; 1971 Sep; 42(3):219-21. PubMed ID: 5151824
    [No Abstract]   [Full Text] [Related]  

  • 24. Leprosy. Recognition and treatment.
    Ramos-e-Silva M; Rebello PF
    Am J Clin Dermatol; 2001; 2(4):203-11. PubMed ID: 11705247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoprophylaxis and BCG vaccination against leprosy.
    Guinto RS
    Int J Lepr Other Mycobact Dis; 1966; 34(3):313-6. PubMed ID: 5950353
    [No Abstract]   [Full Text] [Related]  

  • 26. BCG vaccination of children against leprosy in Uganda: final results.
    Stanley SJ; Howland C; Stone MM; Sutherland I
    J Hyg (Lond); 1981 Oct; 87(2):233-48. PubMed ID: 7288177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leprosy--a complementary contribution.
    Trop Doct; 1973 Jul; 3(3):97-8. PubMed ID: 4736659
    [No Abstract]   [Full Text] [Related]  

  • 28. Prospective immunological follow-up in household contacts of Mexican leprosy patients.
    Amezcua ME; Escobar-Gutiérrez A; Barba-Rubio J; Cázares JV; Mayén E; Chávez-Núñez M; Peña RC; Rodríguez R; Pastén S
    Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):651-9. PubMed ID: 2280115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results.
    Convit J; Sampson C; Zúñiga M; Smith PG; Plata J; Silva J; Molina J; Pinardi ME; Bloom BR; Salgado A
    Lancet; 1992 Feb; 339(8791):446-50. PubMed ID: 1346818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphocyte transformation test in healthy contacts of patients with leprosy. II. Influence of consanguinity with the patient, sex, and age.
    Menzel S; Bjune G; Kronvall G
    Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2):153-9. PubMed ID: 378872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological responsiveness to M. leprae and BCG antigens in 98 leprosy patients and their household contacts.
    Sarno EN; Espinosa M; Sampaio EP; Vieira LM; Figueiredo AA; Miranda CF; Esquenazi D; Salgado JL; Nogueira N
    Braz J Med Biol Res; 1988; 21(3):461-70. PubMed ID: 3147795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.
    Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmission of Hansen's disease and unscreened household contacts.
    Ignotti E; Bayona M; Alvarez-Garriga C; Andrade VL; Valente JG
    Indian J Lepr; 2007; 79(1):11-25. PubMed ID: 17578265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of BCG on the risk of leprosy in an endemic area: a case control study.
    Muliyil J; Nelson KE; Diamond EL
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):229-36. PubMed ID: 2071979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dimorphous leprosy].
    Esca SA; Zelger J
    Hautarzt; 1984 Jun; 35(6):298-302. PubMed ID: 6469634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BCG vaccination of children against leprosy: seven-year findings of the controlled WHO trial in Burma.
    Bechelli LM; Garbajosa PG; Gyi MM; Uemura K; Sundaresan T; Martínez Domínguez V; Matejka M; Tamondong C; Quagliato R; Engler V; Altmann M
    Bull World Health Organ; 1973; 48(3):323-34. PubMed ID: 4270384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of leprosy.
    Crawford CL; Boughton CR
    Lancet; 1972 May; 1(7761):1186-7. PubMed ID: 4113094
    [No Abstract]   [Full Text] [Related]  

  • 38. Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis.
    Richardus JH; Oskam L
    Clin Dermatol; 2015; 33(1):19-25. PubMed ID: 25432807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leprosy incidence and risk estimates in a 33-year contact cohort of leprosy patients.
    Hacker MA; Sales AM; Duppre NC; Sarno EN; Moraes MO
    Sci Rep; 2021 Jan; 11(1):1947. PubMed ID: 33479421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leprosy exposure, infection and disease: a 25-year surveillance study of leprosy patient contacts.
    Sarno EN; Duppre NC; Sales AM; Hacker MA; Nery JA; de Matos HJ
    Mem Inst Oswaldo Cruz; 2012 Dec; 107(8):1054-9. PubMed ID: 23295758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.